These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 23200236

  • 1. Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.
    Matsumoto I, Oda M, Takizawa M, Waseda R, Nakajima K, Kawano M, Mochizuki T, Ikeda H, Watanabe G.
    Ann Thorac Surg; 2013 Jan; 95(1):305-10. PubMed ID: 23200236
    [Abstract] [Full Text] [Related]

  • 2. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
    Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M.
    Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
    [Abstract] [Full Text] [Related]

  • 3. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.
    Tomita M, Ayabe T, Tsuchiya K, Nakamura K.
    Thorac Cardiovasc Surg; 2018 Jun; 66(4):345-349. PubMed ID: 28728209
    [Abstract] [Full Text] [Related]

  • 4. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?
    Viti A, Terzi A, Bianchi A, Bertolaccini L.
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thymic epithelial tumors: Can fluorodeoxyglucose positron emission tomography help in predicting histologic type and stage?
    Purandare NC, Pramesh CS, Karimundackal G, Jiwnani S, Agrawal A, Shah S, Agarwal JP, Prabhash K, Noronha V, Joshi A, Kumar R, Rangarajan V.
    Indian J Cancer; 2016 Jul; 53(2):270-273. PubMed ID: 28071625
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
    Ito T, Suzuki H, Sakairi Y, Wada H, Nakajima T, Yoshino I.
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
    De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S.
    Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
    [Abstract] [Full Text] [Related]

  • 14. Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.
    Lee G, I H, Kim SJ, Pak K, Cho JS, Jeong YJ, Lee CH, Chang S.
    Clin Nucl Med; 2016 Jan; 41(1):8-14. PubMed ID: 26284773
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
    Treglia G, Sadeghi R, Giovanella L, Cafarotti S, Filosso P, Lococo F.
    Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.